|
Market Closed -
London S.E.
02:30:00 2025-05-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.2250 GBX | -.--% |
|
+2.27% | - |
| 03-01 | Kanabo Group PLC Announces Termination Of Director Appointment of Sharon Malka, Effective February 27, 2026 | CI |
| 12-12 | Quantum Helium increases Sagebrush project interest | AN |
| Market Cap | 5.38M 7.27M 6.27M 5.9M 10.11M 690M 10.16M 69.76M 27.15M 351M 27.3M 26.71M 1.16B | P/E 2022 |
-1.15x | P/E 2023 | -1.88x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44M 3.3M 2.84M 2.68M 4.58M 313M 4.61M 31.63M 12.31M 159M 12.38M 12.11M 528M | EV / Sales 2022 |
8.33x | EV / Sales 2023 | 16.5x |
| Free-Float |
93.73% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 week | +2.27% | ||
| Current month | +2.27% | ||
| 1 month | +2.27% | ||
| 3 months | +2.27% |
| Current year | 0.22 |  | 0.22 |
| 1 year | 0.22 | | 0.22 |
| 3 years | 0.15 | | 3.2 |
| 5 years | 0.15 | | 19.5 |
| 10 years | 0.15 | | 51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Avihu Tamir
CEO | Chief Executive Officer | 45 | 2021-06-27 |
Ophir Shimshi
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Avihu Tamir
BRD | Director/Board Member | 45 | 2021-06-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/31/24 | Others | Chairman | 18,011,111 | 2.8479% | ||
| 10/29/24 | Free | Chairman | 17,361,111 | 2.7452% | ||
| 8/28/24 | Buy | Chief Technology Officer | 75,187 | 0.0119% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +2.27% | -.--% | -87.67% | 1.89M | |
| +0.28% | -5.97% | +58.34% | +108.22% | 1,031B | |
| +2.01% | -0.71% | +53.07% | +68.99% | 641B | |
| +1.39% | -2.18% | +23.57% | +75.43% | 453B | |
| -1.50% | -7.04% | +33.55% | +33.94% | 349B | |
| +6.25% | +2.04% | +28.97% | +46.57% | 290B | |
| -0.07% | -4.12% | +0.95% | +11.79% | 252B | |
| +1.92% | -0.93% | +52.28% | +70.67% | 232B | |
| +0.51% | -4.52% | -19.50% | -54.83% | 201B | |
| +2.45% | +0.77% | +32.71% | +95.59% | 181B | |
| Average | +1.45% | -3.62% | +26.39% | +36.87% | 362.98B | |
| Weighted average by Cap. | +1.60% | -3.40% | +38.39% | +66.40% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 603K 816K 704K 662K 1.13M 77.42M 1.14M 7.82M 3.05M 39.38M 3.06M 3M 131M | 895K 1.21M 1.04M 982K 1.68M 115M 1.69M 11.61M 4.52M 58.45M 4.55M 4.45M 194M |
| Net income | -6.87M -9.29M -8.01M -7.54M -12.91M -882M -12.98M -89.11M -34.68M -448M -34.88M -34.12M -1.49B | -7.99M -10.8M -9.32M -8.77M -15.02M -1.03B -15.1M -104M -40.34M -522M -40.57M -39.69M -1.73B |
| Net Debt | -3.01M -4.07M -3.51M -3.31M -5.66M -387M -5.69M -39.09M -15.21M -197M -15.3M -14.97M -652M | -2.94M -3.97M -3.43M -3.22M -5.52M -377M -5.55M -38.13M -14.84M -192M -14.92M -14.6M -636M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- KNB Stock
Select your edition
All financial news and data tailored to specific country editions
